Compounds > candesartan cilexetil

candesartan cilexetil and cv 11194

candesartan cilexetil has been researched along with cv 11194 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furukawa, Y; Inada, Y; Kato, T; Kohara, Y; Kubo, K; Naka, T; Nishikawa, K; Shibouta, Y; Yoshimura, Y1
Giridhar, R; Murumkar, P; Naik, P; Yadav, MR1
Naka, T1

Reviews

2 review(s) available for candesartan cilexetil and cv 11194

ArticleYear
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
    Bioorganic & medicinal chemistry, 2010, Dec-15, Volume: 18, Issue:24

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan

2010
[Angiotensin II receptor antagonist activities and mode of action of benzimidazole-7-carboxylic acid derivatives].
    Nihon rinsho. Japanese journal of clinical medicine, 1993, Volume: 51, Issue:6

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Prodrugs; Structure-Activity Relationship; Tetrazoles

1993

Other Studies

1 other study(ies) available for candesartan cilexetil and cv 11194

ArticleYear
Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids.
    Journal of medicinal chemistry, 1993, Aug-06, Volume: 36, Issue:16

    Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biological Availability; Biphenyl Compounds; Male; Prodrugs; Rats; Rats, Sprague-Dawley; Tetrazoles

1993